PPIUCD in private sector

Prospective study to assess acceptability, safety and expulsion rate of Cu T 380 A in immediate postpartum period

https://doi.org/10.53730/ijhs.v6nS6.11214

Authors

  • Shalini Gupta Assistant professor Dept of Obst & Gynae, Government medical college, Ratlam Madhyapradesh
  • Sarika Rawat Assistant professor Dept of Obst & Gynaec, Government medical college, Ratlam Madhyapradesh
  • Swati Kulhar Consultant (obs & gynae), private nursing home, Jodhpur, (RAJASTHAN)
  • Rekha Vimal Gupta Professor (obs & gynae), Government medical college, Ratlam Madhyapradesh

Keywords:

postpartum IUCD, family planning, complication

Abstract

PPIUCD is preferably inserted within 10 minutes of placenta delivery, intracaesarean, or 48 hours of delivery. In India, 65 percent of women have unmet family planning needs. The goal of this prospective study was to assess the acceptability, safety, and expulsion rate of Cu T 380 after 6 weeks of insertion. The research was conducted at St. Stephen's Hospital in Delhi, a tertiary care facility, in the Department of Obstetrics and Gynecology. For a year, 150 patients of various ages were implanted with PPIUCD. Patients were monitored for 6 weeks to assess- 1) Expulsion rate 2) Safety within Within 6 weeks of insertion, there was no evidence of abdominal pain, foul-smelling vaginal discharge, bleeding, or perforation. 3). Removal reasons In our study, we found that the overall complication rate was 9.29 percent, with infection rate 0.7 percent, prolonged lochia rate 2.1 percent, persistent bleeding rate 3.6 percent, and pain abdomen 1.4 percent. The study's removal rate was 5.0 percent. The rate of expulsion was 2.86 percent. The satisfaction rate was 80%. Based on the findings of this study, we believe that postpartum IUCD should be widely used as a contraceptive.

Downloads

Download data is not yet available.

References

Ananthasubramaniam, L., Premlatha, J. and Ayyar, S. Post placental insertion of copper IUCD. J.Obset.Gynaecol. India, 1988.18:683-6

Amir, . F., Suhron, M., & Sulaihah, S. (2021). Family care model development in treating schizophrenia patients that have self-deficit nursing based system: Structural equation modeling analysis. International Journal of Health & Medical Sciences, 5(1), 7-14. https://doi.org/10.21744/ijhms.v5n1.1808

Celen S, Möröy P, Sucak A, Aktulay A, Danisman N. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception. 2004; 69:279–282.Doi: 10.1016

Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA. 2006 Apr 19; 295(15): 1809-23. Report of a WHO Technical Consultation on Birth Spacing Geneva, Switzerland 13–15 June 2005. Page 2.

Department of reproductive Health and Research. World Health Organization.Medical eligibility criteria for contraceptive use.5th edition [internet]. Geneva (CH): World Health Organization; 2015 [updated April 2015]

Division of Reproductive Health, National center for Chronic Disease Prevention and Health Promotion (US). Reproductive Health – Contraception [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (US); 2015 [reviewed: April 22, 2015 updated: April 22, 2015] available from http://www.cdc.gov/reproductive health/unintended pregnancy/contraception.htm

Eroglu K, Akkuzu G, Vural G, Dilbaz B et al. Comparision of efficacy and complications of IUD insertion in immediate postplacental/ early postpartum period with interval period: 1 year follow-up. Contraception 2006, 74 (5): 376-81. DOI: 10.1016/j.contraception.2006.07.003

Federation of Obstetrics and Gynaecological Societies of India. IUCD and Medical Abortion Survey. [www.fogsi.org]. 2009[updated Oct 2009]

Grimes D, Lopez LM, Schulz KF, Stanwood NL. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev. 2010; Issue 5: CD003036.

Kapp N, Curtis KM. Intrauterine device insertion during the postpartum period: a systematic review. Contraception. 2009; 80: 327-36.

Kittur S, Kabadi YM. Enhancing contraceptive usage by post-placental intrauterine contraceptive devices (PPIUCD) insertion with evaluation of safety, efficacy, and expulsion. Int J ReprodContraceptObstet Gynecol. 2012; 1:26–32. DOI: 10.5455/2320-1770.ijrcog001112

Kumar S, Sethi R, Balasubramaniam S, Charurat E et al. Women’s experience with postpartum intrauterine contraceptive device use in India. Reprod Health. 2014; 11: 32. DOI: 10.1186/1742-4755-11-32

Postpartum IUCD reference manual. Family planning division. Ministry of Health & Family Welfare. November 2010. Page 2. Fig1.1

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Xu JX, Connell C, Chi IC. Immediate postpartum intrauterine device insertion a report on the Chinese experience.AdvContracept. 1994; 10(1): 71-82

Published

28-07-2022

How to Cite

Gupta, S., Rawat, S., Kulhar, S., & Gupta, R. V. (2022). PPIUCD in private sector: Prospective study to assess acceptability, safety and expulsion rate of Cu T 380 A in immediate postpartum period. International Journal of Health Sciences, 6(S6), 6608–6617. https://doi.org/10.53730/ijhs.v6nS6.11214

Issue

Section

Peer Review Articles